Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Debiopharm begins afabicin trial for staphylococcal infections

Scanning electron micrograph of methicillin-resistant Staphylococcus aureus and a dead human neutrophil. Credit: NIAID.



  • Debiopharm begins afabicin Phase II trial in staphylococcal infections

Go Top